183 related articles for article (PubMed ID: 30607125)
1. Survival of patients with subglottic squamous cell carcinoma.
MacNeil SD; Patel K; Liu K; Shariff S; Yoo J; Nichols A; Fung K; Garg AX
Curr Oncol; 2018 Dec; 25(6):e569-e575. PubMed ID: 30607125
[TBL] [Abstract][Full Text] [Related]
2. Subglottic Squamous Cell Carcinoma: A Population-Based Study of 889 Cases.
Marchiano E; Patel DM; Patel TD; Patel AA; Xue YE; Eloy JA; Baredes S; Park RC
Otolaryngol Head Neck Surg; 2016 Feb; 154(2):315-21. PubMed ID: 26607281
[TBL] [Abstract][Full Text] [Related]
3. Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).
Fong PY; Tan SH; Lim DWT; Tan EH; Ng QS; Sommat K; Tan DSW; Ang MK
PLoS One; 2019; 14(11):e0224665. PubMed ID: 31747406
[TBL] [Abstract][Full Text] [Related]
4. [Primary carcinoma of the subglottic larynx].
Erdamar B; Süoğlu Y; Emin AH; Akdağ K; Kiyak E; Sunay T; Cölhan I
Kulak Burun Bogaz Ihtis Derg; 2002; 9(3):198-202. PubMed ID: 12415210
[TBL] [Abstract][Full Text] [Related]
5. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
7. Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx.
Gainor DL; Marchiano E; Bellile E; Spector ME; Taylor JMG; Wolf GT; Hogikyan ND; Prince ME; Bradford CR; Eisbruch A; Worden F; Shuman AG
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):625-630. PubMed ID: 28608731
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of treatment outcomes in patients with supraglottic laryngeal cancer in Ontario, Canada: A population-based study.
Hall SF; Griffiths RJ
Head Neck; 2018 May; 40(5):1024-1033. PubMed ID: 29412495
[TBL] [Abstract][Full Text] [Related]
9. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis of patients with subglottic squamous cell carcinoma based on the SEER database.
Yang F; He L; Rao Y; Feng Y; Wang J
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S70-S80. PubMed ID: 34716102
[TBL] [Abstract][Full Text] [Related]
11. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
12. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
[TBL] [Abstract][Full Text] [Related]
13. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
14. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
[TBL] [Abstract][Full Text] [Related]
15. Results and Survival of Locally Advanced AJCC 7th Edition T4a Laryngeal Squamous Cell Carcinoma Treated with Primary Total Laryngectomy and Postoperative Radiotherapy.
Gorphe P; Matias M; Moya-Plana A; Tabarino F; Blanchard P; Tao Y; Janot F; Temam S
Ann Surg Oncol; 2016 Aug; 23(8):2596-601. PubMed ID: 27034080
[TBL] [Abstract][Full Text] [Related]
16. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.
Vilaseca I; Blanch JL; Berenguer J; Grau JJ; Verger E; Muxí Á; Bernal-Sprekelsen M
Head Neck; 2016 Jul; 38(7):1050-7. PubMed ID: 26872432
[TBL] [Abstract][Full Text] [Related]
17. Treatment, comorbidity and survival in stage III laryngeal cancer.
Connor KL; Pattle S; Kerr GR; Junor E
Head Neck; 2015 May; 37(5):698-706. PubMed ID: 24596316
[TBL] [Abstract][Full Text] [Related]
18. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal preservation in ENT oncology. Retrospective series of 246 patients managed in the Caen University Hospital and François Baclesse Cancer Care Center between 1998 and 2008.
Cuny F; Meunier A; Heutte N; Rame JP; De Raucourt D; Babin E; Blanchard D
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):129-34. PubMed ID: 25838235
[TBL] [Abstract][Full Text] [Related]
20. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
